Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnosis Center for Deafness | RCV001780438 | SCV001984969 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV001780438 | SCV002017687 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | 2020-06-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003560843 | SCV004298174 | pathogenic | not provided | 2023-05-26 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1301978). This premature translational stop signal has been observed in individuals with deafness (PMID: 23208854, 30896630, 33095980, 35346193). This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Arg3134*) in the MYO15A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO15A are known to be pathogenic (PMID: 17546645). |
ENT and Head and Neck Research Center and Department, |
RCV001780438 | SCV005387870 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | 2024-11-02 | criteria provided, single submitter | clinical testing | PVS1: Null variant (nonsense) in gene MYO15A, predicted to cause NMD. Loss-of-function is a known mechanism of disease (gene has 448 reported pathogenic LOF variants). The exon affects 2 functional domains: UniProt protein MYO15_HUMAN domain 'MyTH4 2' and UniProt protein MYO15_HUMAN region of interest 'Tail'. The exon contains 4 pathogenic variants. The truncated region contains 68 pathogenic variants., PM2: GnomAD genomes homozygous allele count = 0 is less than 2 for AR gene MYO15A, good gnomAD genomes coverage = 32.2, PP5: Combined evidence strength is Moderate (score = 2).Moderate: ClinVar classifies this variant as Pathogenic, 2 stars (reviewed Mar '24, 3 submissions), citing 5 articles (35346193, 33095980, 30896630, 23208854 and 17546645). |